This inventor holds 1 USPTO granted patent. Top assignee: Guangzhou Zhiyi Biotechnology Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Innovations of Xiaomin Yi in Metabolic Health
Introduction
Xiaomin Yi is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the area of metabolic health. His work focuses on the use of specific bacterial strains to improve metabolic syndrome, a condition that affects millions worldwide.
Latest Patents
Xiaomin Yi holds a patent for the "Use of Akkermansia muciniphila in preparation of pharmaceutical composition or health care product composition for improving metabolic syndrome." This patent outlines the use of a composition containing Akkermansia muciniphila, specifically strains AM06 and AM02, for the prevention and treatment of metabolic syndrome. The deposit numbers for these strains are CGMCC No. 22793 for AM06 and CGMCC No. 22794 for AM02. This innovative approach aims to enhance metabolic health and provide new avenues for treatment.
Career Highlights
Xiaomin Yi is associated with Guangzhou Zhiyi Biotechnology Co., Ltd., where he applies his expertise in biotechnology to develop health care products. His work is pivotal in advancing the understanding and treatment of metabolic disorders.
Collaborations
Xiaomin Yi collaborates with talented individuals in his field, including Yangyang Liu and Lijun Zheng. These partnerships enhance the research and development efforts at Guangzhou Zhiyi Biotechnology Co., Ltd.
Conclusion
Xiaomin Yi's innovative work in the field of metabolic health through his patent on Akkermansia muciniphila showcases the potential of biotechnology in addressing significant health challenges. His contributions are paving the way for future advancements in the treatment of metabolic syndrome.